The development and widespread availability of effective anticoagulant medications are cornerstones of modern cardiovascular care. Among these, Apixaban stands out as a direct factor Xa inhibitor, offering significant benefits in preventing stroke and systemic embolism in patients with non-valvular atrial fibrillation, as well as treating deep vein thrombosis and pulmonary embolism. The efficacy and safety of Apixaban are intrinsically linked to the quality of its constituent components, particularly the pharmaceutical intermediates used in its synthesis. As a leading manufacturer of high-purity chemical intermediates, NINGBO INNO PHARMCHEM CO.,LTD. recognizes the critical importance of compounds like Ethyl 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate (CAS: 503614-91-3) in this complex process.

This specific intermediate, often referred to by its CAS number 503614-91-3, is a key building block in the intricate multi-step synthesis of Apixaban. Its precise molecular structure and high purity are paramount for ensuring the correct formation of the final active pharmaceutical ingredient (API). Impurities or variations in this intermediate can lead to compromised drug efficacy, increased side effects, or regulatory hurdles. Therefore, pharmaceutical companies and contract development and manufacturing organizations (CDMOs) must partner with reliable suppliers who can guarantee consistent quality and supply. When procurement managers are looking to buy this vital component, they seek not just a product, but a assurance of quality and a stable supply chain from a reputable supplier. Understanding the need for a competitive price without sacrificing quality is also a key consideration for bulk purchase orders.

The journey from raw materials to a finished pharmaceutical product is a testament to advanced chemical synthesis and stringent quality control. Intermediates such as Ethyl 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate represent a crucial stage in this journey. Their production requires specialized expertise in organic chemistry, precise control over reaction conditions, and thorough analytical testing to verify purity and identity. As a dedicated manufacturer based in China, NINGBO INNO PHARMCHEM CO.,LTD. has invested heavily in state-of-the-art facilities and skilled personnel to produce this intermediate to the highest standards. We understand that timely delivery and consistent product availability are critical for our clients' production schedules, and we are committed to providing a seamless procurement experience.

For R&D scientists and procurement specialists in the pharmaceutical industry, sourcing reliable intermediates is a strategic imperative. The availability of high-quality Ethyl 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate from a trusted manufacturer directly impacts the success of drug development and commercialization efforts. We encourage potential clients to contact us to discuss their specific requirements, explore bulk purchase options, and secure a competitive price for this essential pharmaceutical building block. Our goal is to be your preferred supplier, enabling the continuous advancement of life-saving medications.